Home > Tenders > Americas > Panama > Dasatinib 100 Mg, Compressed, V.o. Technical File Acquisition: 103828.

Dasatinib 100 Mg, Compressed, V.o. Technical File Acquisition: 103828. Tender

MINISTRY OF HEALTH has floated a tender for Dasatinib 100 Mg, Compressed, V.o. Technical File Acquisition: 103828.. The project location is Panama and the tender is closing on 15 Sep 2021. The tender notice number is 2021-0-12-11-08-LP-018929, while the TOT Ref Number is 57157613. Bidders can have further information about the tender and can request the complete tender document by Registering on the site.

Procurement Summary

Country : Panama

Summary : Dasatinib 100 Mg, Compressed, V.o. Technical File Acquisition: 103828.

Deadline : 15 Sep 2021

Purchaser's Detail

Purchaser : MINISTRY OF HEALTH
Panama
Delivery Province: Panama
Contact person: Gaspar Garcia
Position:
Telephone: 507-5127193
E-mail: ggarcia@ion.gob.pa
Panama
Email :ggarcia@ion.gob.pa

Other Information

TOT Ref No. : 57157613

Document Ref. No. : 2021-0-12-11-08-LP-018929

Competition : ICB

Financier : Self Financed

Tender Details

Name of the Law: Dasatinib 100 mg, compressed, v.o. Technical tab Acquisition: 103828.
Type of procedure: Public tendering that exceeds B / .50,000 to B / .175,000
Description: Dasatinib 100 mg, compressed, v.o. Technical tab Acquisition: 103828.
Publication date: 07-09-2021 08:27 AM
Date and time Presentation of proposals: 09-15-2021 07:00 AM - 09:00 AM
Opening time and time of the proposal: 09-15-2021 - 09:01 AM
Place of proposals: The presentation of proposals will be electronically, as established in Article 55 of the Sole Text of Law 22, 2006, ordered by Law 153, 2020. Remedy Date: 3 business days after opening date
Maximum date and time of receipt of expressions of interest:
Lodging:

Reference price: 171520.80
Budget Artidas: Number of departure1 012.0.2.502.07.03.244 (2021-2022)
TYPE_OF_AWARD: Global

Call Action

Get A Callback Within 24 Hours

Fill form below to get callback from Tender Experts.

Click button to send your details.